Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Novo Nordisk A/S ADR (NY: NVO )

91.29 UNCHANGED
Streaming Delayed Price Updated: 7:00 PM EDT, Sep 21, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 7,440
Open 91.29
Bid (Size) 91.55 (8)
Ask (Size) 91.61 (2)
Prev. Close 91.29
Today's Range 91.29 - 91.29
52wk Range 90.50 - 201.76
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Don't overlook NYSE:NVO—a stock with solid growth prospects and a reasonable valuation.
In the world of growth stocks, NYSE:NVO shines as a value proposition. 
Via Chartmill
Why Novo Nordisk Stock Was Tumbling on Thursday
A downbeat analyst take resonated with investors. 
Via The Motley Fool

Performance

YTD
-33.35%
-33.35%
1 Month
-50.66%
-50.66%
3 Month
-42.95%
-42.95%
6 Month
-38.97%
-38.97%
1 Year
-7.99%
-7.99%

More News

Read More
Coca-Cola Short Seller Says Dominance Fizzles In Face Of Bubbly Upstarts, Weight Loss Drugs
Via Benzinga
Novo Nordisk Unusual Options Activity For September 21
Via Benzinga
FDA Inspection Turns Up 'Objectionable' Bacteria In Key Novo Nordisk Plant
Via Investor's Business Daily
Exposures Product Safety
Why Novo Nordisk Stock Edged Higher Today
Via The Motley Fool
Why Novo Nordisk Stock Dipped Today
Via The Motley Fool
$1000 Invested In This Stock 10 Years Ago Would Be Worth $5,700 Today
Via Benzinga
Should You Buy Ozempic Maker Novo Nordisk Before Its Stock Split?
Via The Motley Fool
Ypsomed To Supply Autoinjectors To Novo Nordisk Under Long-Term Agreement
Via Benzinga
Eli Lilly Cracks Down on Counterfeit Mounjaro Wight Loss and Diabetes Drugs, Sues Lawsuit Against Clinics
Via Benzinga
Topics Lawsuit
Exposures Financial Legal
Flee to Healthcare Stocks if Recession Rears its Head?
Via MarketBeat
Topics Economy
Exposures Economy Interest Rates
Amazon Poaches Microsoft's Product Chief, Google And DoD Team Up For AI-Powered Microscope To Identify Cancer, Rocket Lab's 41st Mission Succumbed To Technical Issues: Today's Top Stories
Via Benzinga
Novo Nordisk Partners With South Africa-Based Aspen To Supply Insulin For African Countries
Via Benzinga
Could Ely Lilly Be the Best Pharma Stock to Own Now and Forever?
Via MarketBeat
Single Bitcoin In 2021 Was Enough To Purchase A Tesla Model Y, Softbank Explores Investing In OpenAI, Ford Faces UAW Strike In US, Canada: Today's Top Stories
Via Benzinga
Novo Nordisk Dives After FDA Reportedly Finds 'Objectionable' Conditions At A Key Wegovy Plant
Via Investor's Business Daily
Exposures Product Safety
Quality Control Issues at Novo Nordisk's Clayton Plant - Key Site for Weight-Loss, Diabetes Drug Production
Via Benzinga
Exposures Product Safety
3 Phenomenal Stock-Split Stocks You Should Be Buying Now
Via InvestorPlace
3 Stock-Split Stocks Billionaire Investors Can't Stop Buying
Via The Motley Fool
Yet Again, Ozempic Could Soon Get Even Better for Novo Nordisk Stock
Via The Motley Fool
The 7 Most Undervalued Cathie Wood Stocks to Buy in September 2023
Via InvestorPlace
3 (Bad) Reasons to Avoid or Sell Novo Nordisk Stock
Via The Motley Fool
3 Top Healthcare Stocks Defying the Bear Market
Via The Motley Fool
This Stock Is Lifting an Entire Country's Economy -- Is It a Buy?
Via The Motley Fool
Topics Economy
Exposures Economy
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.